glutathione in ovarian cancer a double-edged sword Role of SLC7A11/xCT Ferroptosis—The “Double-Edged Sword” in Cancer:
FerroptosisThe Double Edged Sword in Cancer: Mechanisms of Tumor Suppression Resistance and Therapeutic Manipulation Frontiers Targeting ferroptosis: a promising avenue for ovarian cancer treatment Frontiers Ferroptosis: a dual edged sword in tumour growth Cysteine metabolic circuitries: druggable targets in cancer British Journal of Cancer
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



